Thu, Jan 25, 2024
As of 10:37 a.m., shares of Laurus Labs traded 7.14 per cent, or Rs 28.45, lower on the BSE at Rs 370.1 apiece. The market capitalisation of the company at around the same time stood at Rs 19,947.13 crore.
More >
Fri, Oct 20, 2023
Laurus Labs dividend: Laurus Labs on Friday, October 20 announced a 20 per cent payout to its shareholders for the financial year 2023-24 along with its quaterly earning report.
Mon, Jun 19, 2023
The two partners have signed a Memorandum of Understanding under which Laurus Labs will in-license few gene therapy assets and provide research grants for advancing these products through the pre-clinical development, the company said in a regulatory filing.
Thu, Jun 01, 2023
Laurus Labs share price NSE: Shares of Laurus Labs Ltd, NSE: LAURUSLABS surged on June 1. The stock opened at Rs 334.65, up over 2 per cent from its Wednesday's close of Rs 330.7 on the NSE.
Fri, May 12, 2023
Exports of Biocon, Divi's Laboratories, Laurus Labs and Gland Pharma decreased in April. Why did pharma exports decline in April? Know from Nupur in this video.
Thu, Apr 27, 2023
Drug firm Laurus Labs Ltd on Thursday reported a 56 percent year-on-year (YoY) drop in net profit at Rs 103 crore for the fourth quarter that ended March 31, 2023. Watch the full news in this video.
EBITDA for the quarter came in at Rs 287 crore, up 28 per cent YoY while EBITDA margins came in at 20.8 per cent.
Mon, Jan 30, 2023
State-run insurance major Life Insurance Corporation (LIC) held 2.7 per cent in the mid-cap pharma company, according to the data.
Mon, Dec 19, 2022
In today's edition of Traders Diary, Zee Business research team brings its exclusive research on 20 stocks that investors and traders can refer to while making their strategies in them
Tue, Nov 29, 2022
Why the downgrade on Laurus Labs? Why is the stock falling? Know the complete details from Nupur.
Sat, Oct 15, 2022
Factors such as good monsoon, higher reservoir levels, cool-off in commodity prices, and healthy job/labour market cumulatively indicate that the domestic economy would accommodate the prevailing inflation rather smoothly, Axis Securities said in its report.
Mon, Feb 14, 2022
Laurus Labs Ltd rallied by about 50 per cent in the last one year compared to over 14 per cent upside seen in the Nifty50 and 17 per cent gain seen in the S&P BSE 200 index in the same period
Fri, Jan 28, 2022
On the back of heavy volumes and a positive outlook, the shares of a mid-cap pharma company – Laurus Labs - jumped almost 17 per cent from the day’s low of Rs 433.2 per share.
Thu, Jan 27, 2022
Many listed companies today announced their Q3FY22 results on Thursday. Some of the companies which announced the December quarter results include Route Mobile, Transport Corporation of India, India Grid Trust, Laurus Labs and BHEL
Fri, Jan 21, 2022
Drug firm Laurus Labs on Friday said it has inked a pact with Geneva-based MPP (Medicine Patient Pool) for manufacturing the oral COVID-19 antiviral medication molnupiravir.
Thu, Jan 06, 2022
Indian market closed in the green for the fourth consecutive day in a row on Wednesday. The S&P BSE Sensex closed above 60,000 while the Nifty50 reclaimed the 17900 level towards the close.
Fri, Nov 19, 2021
Laurus Labs on Friday said it has signed an investment agreement with Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an advanced cell and gene therapy company, to acquire 26.62 per cent stake on fully diluted basis for about Rs 46 crore.
Tue, Apr 27, 2021
Zee Business Managing Editor Anil Singhvi said that Laurus Labs is expected to post strong quarterly numbers on 29th April. Market Expert, Rakesh Bansal said that ahead of results, this stock can be purchased with stop-loss of Rs 433
Tue, Apr 13, 2021
Stocks to Buy with Anil Singhvi – Laurus Labs - Stock Market Experts Kunal Saraogi and Rakesh Bansal today gave yet another Special Pick which they said will bring windfall gains for the investors. The experts said that the pharma stocks are now in focus. The stock picked today was Laurus Labs. Know why these experts are bullish on this stocks and what gains is it expected to give to the investors
Wed, Apr 07, 2021
Laurus Labs share price today is Rs 420, up Rs 23.5 or 6%. Laurus Labs share price has moved up from Rs 359 to Rs 420 in the last one week. Antique Stock Broking says that Laurus Labs is a leading research driven manufacturing Company. With process chemistry and R&D as its core Laurus has successfully gained leadership in various (Antiretroviral) ARV APIs and formulations in Low Middle Income Countries
Thu, Mar 11, 2021
Sharekhan had an interaction with Laurus Labs management and their commentary was positive, pointing towards a robust growth outlook. Laurus’ formulations business is on a strong growth footing, backed by a higher quantum of launches in the US as well as opportunities from in-licensing of products, in addition to traction in anti-retrovirals (ARVs).
Mon, Feb 01, 2021
Anand Rathi maintains Buy rating on Laurus Labs with a target price of Rs 424 per share. Laurus Lab reported consolidated revenues of Rs 12880 mn showcasing strong growth of 76% for the quarter and Rs 34020 mn for 9M FY21 growing by 71% driven by growth in all the divisions.
Wed, Dec 23, 2020
Laurus’ formulations business is gaining traction with the tender business, which accounts for around three-fourth of total formulation sales, and is witnessing sturdy growth. Moreover, Laurus is expanding capacities, primarily through brownfield expansions to cater to increasing demand. The first leg of debottlenecking is expected to be completed by Q4FY2021-end, while the second leg would be completed in two phases by September 2021 and December 2021. Cumulatively, the formulations capacity would increase by 80% in the next two years.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
